Immunoassays – News and Features

New study suggests harmful algal bloom toxicity varies over the summer.

A new nanoporous membrane allows highly efficient separation of wastewater components for reuse, offering industries sustainability and added-value benefits.

Based on decades of work to uncover the underlying mechanisms of asthma and other respiratory conditions, researchers have produced a simple, rapid test that can identify the presence of a key driver of severe asthma.

According to research, a green tea compound called epigallocatechin gallate could be promising for both preventing and treating uterine fibroids.

Revvity announced its newly established Scientific Centre of Excellence in Cambridge, where scientists can outsource their research needs to Revvity experts. Technology Networks visited the site to learn more about how Revvity is supporting its customers in their drug discovery efforts.

A specific combination of oncogenes found to support cancer growth and survival, resulting in unfavourable treatment outcome.

By combining multiple advanced technologies into a single system, EPFL researchers have made a significant step forward in diagnosing neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.

An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer.

University of California Los Angeles (UCLA) Health scientists discover that treating a mouse model of multiple sclerosis (MS) with estriol reverses the breakdown of myelin in the cortex of the brain. The research is published in Laboratory Investigation.

Recently, scientists developed a new technology for early screening and monitoring of cervical precancerous lesions.